CYP24A1 and hypercalcemia disease: This may in turn suppress PTH in the fetus and may explain why newborns of mothers with CYP24A1 mutations are at risk of both, hypercalcemia due to transfer of calcium from the mother during pregnancy and of hypocalcemia due to suppression of PTH.